APA

Alkner S., Jensen M., Rasmussen B. B., Bendahl P., Fernö M., Rydén L. & Mouridsen H. (20180607). Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98. : Breast cancer research and treatment.

Chicago

Alkner S, Jensen M-B, Rasmussen B B, Bendahl P-O, Fernö M, Rydén L and Mouridsen H. 20180607. Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98. : Breast cancer research and treatment.

Harvard

Alkner S., Jensen M., Rasmussen B. B., Bendahl P., Fernö M., Rydén L. and Mouridsen H. (20180607). Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98. : Breast cancer research and treatment.

MLA

Alkner S, Jensen M-B, Rasmussen B B, Bendahl P-O, Fernö M, Rydén L and Mouridsen H. Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98. : Breast cancer research and treatment. 20180607.